Bright Minds Biosciences (DRUG) Cash on Hand

DRUG Cash on Hand in 2022: $4.96M

According to Bright Minds Biosciences latest financial reports the cash on hand of DRUG is $4.96M, an decrease of -41.97% to 2022. At the end of 2022 company had $8.55M cash on hand. This amount reflects the liquid assets available to the company, which are crucial for its operational flexibility, investment opportunities, and overall financial security.

DRUG Cash on Hand History from 2020 to 2023

DRUG Cash on Hand by year

View the Top Cash on Hand Companies